1. Disease Overview

Abdominal aortic aneurysm (AAA) is a balloon-like bulge or dilation in the abdominal section of the aorta, the largest artery in the body. The aorta carries oxygen-rich blood from the heart to the rest of the body, and when its wall weakens in the abdominal region, it can expand like an inflating balloon. AAA typically develops slowly over many years, often without symptoms, but poses a serious risk because it can rupture—causing life-threatening internal bleeding. The risk of rupture increases with aneurysm size, growth rate, and specific risk factors. AAA affects approximately 1-4% of adults over 50, with men affected 4-6 times more often than women. Most AAAs are detected incidentally during imaging for other conditions, though screening programs exist for high-risk groups. Treatment involves regular surveillance for smaller aneurysms and elective repair (either open surgical repair or endovascular stent grafting) once the aneurysm reaches a size threshold where rupture risk outweighs procedural risk. With modern techniques, AAA can be managed successfully in most patients, though ruptured AAA remains a medical emergency with high mortality even with prompt surgical intervention.

2. Key Facts at a Glance

Aspect	Details
Also known as	AAA, abdominal aortic aneurysm, aortic aneurysm (abdominal)
Body system affected	Vascular system (abdominal aorta, the main artery carrying blood from heart to lower body)
Common in	Men over 65, smokers, those with high blood pressure, family history, atherosclerosis
Severity range	Asymptomatic small aneurysm (low risk) to large aneurysm (high rupture risk) to ruptured AAA (life-threatening emergency)
Key treatments	Surveillance (ultrasound/CT monitoring), blood pressure control, smoking cessation, endovascular aneurysm repair (EVAR), open surgical repair
Outlook	Excellent with early detection and appropriate treatment; ruptured AAA has high mortality (70-90%) even with surgery

3. Alternative Names and Medical Terminology

Abdominal aortic aneurysm (AAA) — Most common term, specifies location in abdominal aorta
Aortic aneurysm — General term; may refer to abdominal or thoracic aorta
Infrarenal aneurysm — AAA located below the renal arteries (most common type)
Suprarenal aneurysm — AAA located above the renal arteries (more complex to treat)
Juxtarenal aneurysm — AAA involving the renal arteries
Aortic ectasia — Mild dilation (<1.5× normal diameter), often considered early aneurysm
Aortic rupture — Complete tear in aneurysm wall, causing catastrophic bleeding
Aortic dissection — Tear in inner aortic layer (different from rupture, though can coexist)
EVAR — Endovascular aneurysm repair, stent graft placement through catheters
Open repair — Traditional surgical replacement of weakened aortic segment

4. Relevant Heart, Lung or Vascular Anatomy

The aorta is the body’s largest artery, originating from the heart’s left ventricle and extending downward through the chest and abdomen:

Aortic segments:

Ascending aorta — Rises from left ventricle, gives off coronary arteries
Aortic arch — Curves downward, gives off branches to head and arms
Descending thoracic aorta — Passes through chest
Abdominal aorta — Passes through diaphragm at level of T12 vertebra, continues to level of L4 where it bifurcates into common iliac arteries

Abdominal aorta anatomy:

Diameter — Typically 1.5-2.0 cm at renal arteries, gradually tapering
Branches — Renal arteries (to kidneys), mesenteric arteries (to intestines), iliac arteries (to legs)
Location — Retroperitoneal (behind abdominal cavity), just anterior to spine
Relationship to organs — Posterior to pancreas, duodenum, left renal vein

Aortic wall layers:

Intima — Inner endothelial lining
Media — Middle muscular/elastic layer (weakened in AAA)
Adventitia — Outer fibrous layer

AAA most commonly occurs in the infrarenal segment (below renal arteries) because this area has relatively less blood flow and fewer vasa vasorum (small vessels supplying the aortic wall), making it more vulnerable to degeneration.

5. How the Disease Affects the Body

In AAA, the aortic wall weakens and gradually expands under constant pressure from circulating blood:

Pathophysiology:

Aortic wall degeneration — Loss of elastic fibers, smooth muscle cell death, inflammation, and proteolytic enzyme activity degrade the media layer
Pressure effect — Blood pressure (especially systolic) continually stresses weakened wall
Progressive dilation — Aneurysm enlarges over years at variable rates (average 2-4 mm/year, but highly variable)
Wall stress increases — Laplace law: wall stress = (pressure × radius) / wall thickness; as radius increases, wall stress rises disproportionately
Rupture risk — When wall stress exceeds wall strength, catastrophic tearing occurs

Effects of rupture:

Massive retroperitoneal bleeding — Blood accumulates behind abdominal cavity
Hypovolemic shock — Blood pressure drops catastrophically
Organ failure — Kidneys, intestines, other organs lose perfusion
Death — Most patients die before reaching hospital; even with surgery, mortality is high

Effects on nearby structures:

Compression of duodenum — Can cause early satiety, nausea
Ureteral obstruction — Rarely causes kidney problems
Venous compression — Can cause leg swelling (rare)
Inflammatory response — Some AAAs cause inflammation/fibrosis around aorta (“inflammatory aneurysm”)

Systemic effects:

Thrombus formation — Laminated blood clot lines aneurysm sac; may embolize
Cardiovascular risk association — AAA patients often have widespread atherosclerosis (coronary artery disease, peripheral artery disease, carotid disease)

6. Types and Classification

AAA is classified by several systems:

By size:

Small AAA — 3.0-4.4 cm in diameter (surveillance typically recommended)
Medium AAA — 4.5-5.4 cm (consider repair depending on other factors)
Large AAA — ≥5.5 cm (repair generally recommended due to rupture risk)
Giant AAA — >7 cm (high rupture risk, urgent repair)

By location relative to renal arteries:

Infrarenal AAA — Below renal arteries (90-95% of cases, most treatable with EVAR)
Juxtarenal AAA — Extends to renal artery origins (more complex)
Suprarenal AAA — Extends above renal arteries (requires more complex repair)
Thoracoabdominal AAA — Extends from chest into abdomen (most complex)

By morphology:

Fusiform — Circumferential dilation (most common)
Saccular — Localized outpouching on one side (higher rupture risk)
Mycotic — Infection-related aneurysm (rare, high rupture risk)

By symptoms:

Asymptomatic (incidental) — Detected on imaging for other reasons
Symptomatic (non-ruptured) — Pain, discomfort without rupture
Ruptured — Emergency with bleeding, shock

By wall characteristics:

Standard AAA — Typical atherosclerotic aneurysm
Inflammatory AAA — Thickened wall, periaortic fibrosis, inflammation (2-10% of cases)
Mycotic/infectious AAA — Infection-related, rapid expansion, high rupture risk

7. Causes of the Disease

The primary cause of AAA is degeneration of the aortic wall:

Atherosclerosis:

Chronic inflammation in aortic wall
Lipid accumulation and plaque formation
Proteolytic enzyme activity — Matrix metalloproteinases (MMPs) degrade elastin and collagen
Oxidative stress — Damages aortic wall cells
Most AAAs are associated with atherosclerotic disease

Genetic/familial factors:

Family history — First-degree relative with AAA increases risk 3-5 fold
Genetic predisposition — Multiple genes involved in connective tissue integrity
Inherited connective tissue disorders — Ehlers-Danlos, Marfan (more commonly affect thoracic aorta)

Hemodynamic factors:

Hypertension — Increased pressure stresses aortic wall
High systolic pressure — Particularly damaging
Turbulent flow — At branch points may contribute to wall stress

Inflammatory causes:

Inflammatory AAA — Autoimmune component, thickened wall, periaortic inflammation
Infectious (mycotic) aneurysms — Bacterial infection of aortic wall (rare but dangerous)

Other contributing factors:

Smoking — Major modifiable risk factor, damages aortic wall directly
Age — Degenerative changes accumulate over decades
Male sex — Men more affected (unknown reasons, possibly hormonal)
Emphysema/COPD — Associated through smoking and protease-antiprotease imbalance
Trauma — Rare, but can cause pseudoaneurysm (contained rupture)

Most AAAs are multifactorial — genetic predisposition plus environmental triggers (especially smoking and hypertension) lead to aortic wall degeneration over decades.

8. How the Disease Develops

AAA develops slowly over many years through a degenerative process:

Early stage (decades 1-3):

Endothelial injury from hypertension, smoking, inflammation
Lipid infiltration into aortic wall
Inflammatory cell infiltration — Macrophages, lymphocytes
Protease activation — MMPs degrade elastin and collagen
Mild dilation — May be subtle or undetectable

Progression stage (decades 3-5):

Significant elastin loss — Wall loses elasticity
Smooth muscle cell death — Wall weakens structurally
Compensatory remodeling — Wall tries to maintain integrity
Progressive enlargement — Gradual dilation over years
Thrombus formation — Laminated clot lines aneurysm sac

Advanced stage:

Critical enlargement — >5.5 cm diameter, high rupture risk
Wall stress increases — Laplace law effect
Further weakening — Positive feedback cycle
Rupture imminent — Without intervention

Rupture mechanism:

Wall stress exceeds strength — At critical size/thickness ratio
Tear in media — Usually at point of maximum stress
Retroperitoneal bleeding — Blood dissects behind abdominal cavity
Hypovolemic shock — Circulatory collapse
Multiorgan failure — If not rapidly treated

Growth rate variability:

Average — 2-4 mm/year
Highly variable — Some grow <1 mm/year, others >10 mm/year
Unpredictable — Cannot reliably predict which will rapidly expand
Smoking, hypertension — Associated with faster growth
Large AAAs — Tend to grow faster than small ones

Why surveillance is essential: Regular monitoring detects rapid expansion before rupture occurs.

9. Risk Factors

Modifiable risk factors (can be changed):

Smoking — Single strongest modifiable risk factor; current smokers have 3-5× higher risk; risk decreases after quitting but never returns to baseline
Hypertension — High blood pressure accelerates aneurysm growth and rupture risk; systolic pressure particularly important
Hypercholesterolemia — High cholesterol contributes to atherosclerosis
Obesity — Increases systemic inflammation and atherosclerotic burden
Physical inactivity — Contributes to poor vascular health
Poor diet — High in saturated fats, processed foods accelerates atherosclerosis

Non-modifiable risk factors:

Age — Risk increases dramatically after 65; uncommon before 55
Male sex — Men 4-6× more likely than women; women with AAA tend to present older and have higher rupture risk
Family history — First-degree relative with AAA increases risk 3-5 fold; suggests genetic component
Genetic factors — Certain genes involved in connective tissue and inflammation
Race/ethnicity — More common in Caucasian populations; less common in Asian, African populations

Associated conditions:

Atherosclerosis elsewhere — Coronary artery disease, peripheral artery disease, carotid disease often coexist
COPD/emphysema — Smoking-related association; protease-antiprotease imbalance may contribute
Connective tissue disorders — Ehlers-Danlos, Marfan (though these more commonly cause thoracic aneurysms)
Previous aneurysm repair — Risk of new aneurysm at other sites

Protective factors:

Female sex — Lower risk (though women may have worse outcomes when affected)
Never smoking — Substantially lower risk
Normal blood pressure — Reduces growth and rupture risk
Regular exercise — Improves overall vascular health

Risk is cumulative — Multiple risk factors multiply overall risk.

10. Genetic and Family-History Factors

Genetics plays a significant role in AAA development:

Familial aggregation:

First-degree relative with AAA increases risk 3-5 fold
Familial AAA accounts for ~15-25% of all cases
Brother with AAA — Particularly strong risk factor for male siblings
Multigenerational cases — Documented in many families

Genetic factors:

Polygenic inheritance — Multiple genes contribute, each with small effect
Specific gene variants — Associated with increased risk (genes related to inflammation, extracellular matrix, lipid metabolism)
Genome-wide association studies — Identified multiple risk loci
Heritability estimated at ~70% in twin studies

Inherited connective tissue disorders:

Ehlers-Danlos syndrome — Defective collagen, can cause AAA (though more commonly vascular complications elsewhere)
Marfan syndrome — Fibrillin-1 defect, typically causes thoracic aortic aneurysms but may involve abdomen
Loeys-Dietz syndrome — TGF-β signaling defect, widespread aneurysm risk

Implications for family members:

Screening recommended for first-degree relatives (especially brothers) of AAA patients
Ultrasound screening starting at age 50-55 (or 10 years before earliest case in family)
Lifestyle modifications especially important for those with family history
Aggressive risk factor control — Blood pressure, cholesterol, smoking avoidance

Genetic testing:

Not routinely recommended for most AAA patients
Considered for young patients (<50) or those with multiple aneurysms
Available for specific connective tissue disorders when suspected

Family history matters — If you have a relative with AAA, discuss screening with your doctor.

11. Who Is Most at Risk?

Highest-risk groups:

Men over 65 — Primary demographic; men 4-6× more likely than women
Current or former smokers — Particularly heavy, long-term smokers
Those with hypertension — Especially poorly controlled
Patients with known atherosclerotic disease — CAD, PAD, carotid disease
Those with family history — Especially male siblings with AAA
Caucasian ethnicity — Higher prevalence than other racial/ethnic groups
COPD/emphysema patients — Smoking-related lung disease association

High-risk profile:

65+ year old male smoker with hypertension and family history represents highest risk
Multiple risk factors multiply risk exponentially
Previous aneurysm — Risk of new aneurysm elsewhere

Women with risk factors:

Lower overall incidence but higher rupture risk when present
Often diagnosed older — Average 5-10 years later than men
Worse outcomes — Higher mortality from rupture and repair
May be under-screened — Traditionally considered lower risk

Young patients (<50):

Uncommon without genetic predisposition
Strongly associated with connective tissue disorders, heavy smoking, family history
Need evaluation for underlying genetic conditions if no obvious risk factors

Screening recommendations:

One-time ultrasound recommended for men 65-75 who have ever smoked
Consider screening for men 65-75 never smokers with other risk factors
Consider screening for women with significant risk factors or family history
Screen first-degree relatives (especially brothers) of AAA patients

Know your risk — Discuss AAA screening with your doctor if you have multiple risk factors.

12. Prevalence and Epidemiology

AAA is a significant public health concern:

Overall prevalence:

Affects 1-4% of adults over age 50
Increases with age — <1% at age 50, 4-8% at age 70-80
Male predominance — Men 4-6× more likely than women
Geographic variation — Higher in developed countries, lower in Asia

Age and sex distribution:

Uncommon before 55 — Rare in patients under 50 without genetic predisposition
Peak prevalence — 70s and 80s
Sex ratio — Approximately 5:1 male:female ratio
Women present later and with higher rupture rates

Screening-detected prevalence:

US screening studies — 4-6% prevalence in screened population
UK MASS trial — 4.9% prevalence in men 65-74
European studies — Similar rates in screened populations

Rupture incidence:

Ruptured AAA incidence — 5-10 per 100,000 population annually
Decreasing in some countries — Due to screening programs and reduced smoking
Still common cause of death — 10th-15th leading cause of death in elderly men in some countries

Mortality:

Ruptured AAA — Overall mortality 70-90% even with treatment
Elective repair mortality — 1-5% for open repair, 1-3% for EVAR (lower risk, but not zero)
Screening programs reduce AAA mortality by ~40-50% in screened populations

Temporal trends:

Increasing prevalence — Aging population, better detection
Decreasing rupture incidence — In countries with screening programs
EVAR adoption — Has expanded treatment to older, higher-risk patients

Economic burden:

Significant healthcare costs — Emergency rupture care, elective repair, surveillance
Cost-effective screening — One-time ultrasound highly cost-effective in at-risk groups

AAA remains a major cause of preventable death in aging populations.

13. Signs and Symptoms

Most AAAs are asymptomatic until they rupture or become very large:

Asymptomatic AAA (most common presentation):

No symptoms — Detected incidentally on imaging for other reasons
May be palpable — Pulsatile abdominal mass (sometimes found on routine physical exam)
Usually stable — May enlarge slowly without symptoms

Symptomatic (non-ruptured) AAA:

Abdominal pain — Deep, boring, constant pain in abdomen, flank, or back
Back pain — Lumbar region, may radiate to groin
Abdominal fullness — Sensation of pressure or bloating
Pulsatile sensation — Feeling of pulsation in abdomen
Early satiety — Feeling full quickly when eating (from compression)
Nausea, vomiting — Less common
Weight loss — Unintentional (rare, advanced disease)

Ruptured AAA (medical emergency):

Sudden severe pain — Abdomen, back, flank; described as “tearing” or “ripping”
Hypotension/shock — Low blood pressure, fainting, collapse
Pale, clammy skin — Signs of shock
Rapid pulse — Compensatory tachycardia
Abdominal rigidity — Guarding, muscle rigidity
Loss of consciousness — May be initial presentation

Symptoms related to compression:

Ureteral obstruction — Flank pain, kidney problems (rare)
Venous compression — Leg swelling (rare)
Duodenal compression — Early satiety, vomiting (rare)

Important: AAA symptoms can mimic other abdominal conditions (kidney stones, diverticulitis, back pain). Maintain high index of suspicion in older patients with abdominal/back pain, especially men with risk factors.

14. Early-Stage Symptoms

Early AAA typically causes NO symptoms:

Silent disease:

Most small AAAs (<5 cm) are completely asymptomatic
Detected incidentally — On ultrasound, CT, MRI for unrelated problems
May be discovered — On routine physical exam (pulsatile mass)
Gradual enlargement — No symptoms during early expansion

Subtle symptoms when present:

Mild abdominal discomfort — Vague, non-specific, often ignored
Lower back ache — Dull, intermittent, attributed to aging/musculoskeletal
Sensation of pulsation — In abdomen, noticed when lying down
Mild early satiety — Feeling full sooner than usual (from aneurysm size)

Why symptoms are absent:

Slow development — Gradual enlargement allows adaptation
Location — Retroperitoneal, not directly irritating abdominal wall
No nerve compression — Until very large or ruptured
No organ dysfunction — Until rupture or compression

Early detection challenges:

No screening in many regions — Incidental detection relies on healthcare access
Symptoms attributed to other causes — Back pain, indigestion, aging
Physical exam insensitive — Obesity, abdominal girth limit palpation
Many patients unaware — Never discover AAA until rupture or incidental imaging

Screening value:

Ultrasound screening detects asymptomatic AAA before symptoms/rupture
One-time screening recommended for men 65-75 who have ever smoked
Screening saves lives — By detecting AAA before rupture

Bottom line: Early AAA is a silent disease. If you’re in a high-risk group, discuss screening with your doctor.

15. Advanced-Stage Symptoms

Large or rapidly expanding AAAs may cause symptoms:

Large AAA (>5.5 cm) symptoms:

Persistent abdominal pain — Deep, boring, constant; may radiate to back or flank
Severe back pain — Lumbar region, may radiate to groin
Abdominal pulsation — Visible pulsation through abdominal wall
Abdominal fullness — Constant sensation of pressure
Early satiety — Feeling full quickly, weight loss (from duodenal compression)
Groin pain — From iliac artery involvement

Rapidly expanding AAA:

Worsening pain — Increasing severity over days to weeks
New-onset severe pain — In previously asymptomatic patient
Back/abdominal pain — That doesn’t improve with position change
Tenderness — Abdomen may be tender to palpation

Symptomatic (non-ruptured) AAA features:

Pain is present — Unlike silent, asymptomatic AAA
Vital signs stable — No hypotension or shock
Pain may be chronic — Weeks to months of discomfort
Warning sign — Pain signals impending rupture; urgent evaluation needed

Symptoms of compression:

Ureteral obstruction — Flank pain, decreased urine output, hydronephrosis
IVC compression — Bilateral leg swelling
Duodenal compression — Early satiety, vomiting, weight loss
Lumbar nerve root compression — Radicular pain, numbness (rare)

Pre-rupture symptoms (medical urgency):

Severe acute pain — Often abdomen/back/flank
Pain radiating to groin — Suggests iliac involvement
Hypotension — May be transient (sentinel bleed)
Tachycardia — Early compensatory response
Pallor, diaphoresis — Signs of shock

Any symptomatic AAA requires urgent evaluation — Pain may herald imminent rupture.

16. Symptoms in Women, Men and Older Adults

Women with AAA:

Different presentation:

Later age — Typically present 5-10 years older than men
Higher rupture rate — When diagnosed, more likely to have already ruptured
Higher surgical mortality — Worse outcomes from both elective and emergency repair
Smaller aneurysms may rupture — Some evidence women rupture at smaller diameters
Often under-screened — Traditionally considered “lower risk”

Symptom patterns:

Similar symptoms — Abdominal/back pain as in men
May be overlooked — Lower index of suspicion in women
Ruptured AAA mimics — Other abdominal emergencies (ovarian pathology, diverticulitis)

Men with AAA:

Typical presentation:

Higher prevalence — 4-6× more common than women
Incidental detection — Often found on imaging for other reasons
Physical exam finding — Pulsatile abdominal mass sometimes palpable
Screening-eligible — Men 65-75 who ever smoked should undergo one-time ultrasound

Older adults (75+):

Atypical features:

More comorbidities — Multiple medical problems complicate presentation
Attribution to aging — Symptoms may be dismissed as “just getting older”
Surgical higher risk — Age-related decline in physiological reserve
Decision-making complexity — Balance aneurysm risk vs. surgical risk

Special considerations:

Frailty — Affects treatment options and recovery
Cognitive impairment — May affect symptom reporting
Limited life expectancy — May influence surveillance vs. repair decisions
Multimorbidity — Other conditions may take priority

Bottom line: While men are at higher risk, women with AAA often fare worse and may present later. Maintain high index of suspicion in all at-risk patients, regardless of sex or age.

17. Emergency Warning Signs

Call emergency services immediately (911, 112, or local emergency number) for:

Classic rupture symptoms:

Sudden, severe abdominal or back pain — Described as “tearing,” “ripping,” or “worst pain ever”
Pain radiating to groin or flank — Suggests iliac artery involvement
Feeling of impending doom — “Something terrible is happening”
Syncope or near-syncope — Fainting or feeling like you might faint
Severe weakness — Inability to stand or walk
Cold, clammy skin — Pale, diaphoretic (profuse sweating)

Signs of shock:

Marked hypotension — Low blood pressure, often undetectable
Rapid, weak pulse — Tachycardia with poor perfusion
Altered mental status — Confusion, lethargy, unresponsiveness
Shallow breathing — Respiratory compromise
Loss of consciousness — Cardiac arrest imminent

Pre-rupture symptoms (urgent, not quite emergency but requires immediate care):

New severe abdominal/back pain in patient with known AAA
Worsening pain over hours to days
Pain at rest — Not related to activity
Constant pain — That doesn’t improve with position change

Red flags in patients with known AAA:

Known large AAA (>5.5 cm) with new symptoms
Rapid expansion — Significant growth in short time
Any pain in patient with known AAA (assume impending rupture until proven otherwise)

Don’t delay: Ruptured AAA mortality increases by ~2% per hour after symptom onset. Every minute counts.

Emergency department presentation: Inform triage immediately if you have known AAA or severe abdominal/back pain with shock symptoms—this is a surgical emergency requiring immediate imaging and vascular surgery consultation.

18. When to Seek Medical Help

Seek emergency care (911 or emergency department) for:

Sudden severe abdominal, back, or flank pain — Especially if tearing quality
Pain with hypotension, fainting, or shock symptoms — Signs of rupture
Known AAA with new or worsening pain — Assume impending rupture
Any symptoms suggesting rupture (see section 17)

Seek urgent same-day evaluation for:

New persistent abdominal or back pain — Especially if deep, boring quality
Abdominal pulsation — New sensation of pulsation in abdomen
Unexplained abdominal fullness — Constant sensation of pressure
Known AAA with any new symptoms
Family history of AAA and concerning symptoms

Schedule routine evaluation for:

AAA screening — Men 65-75 who have ever smoked (one-time ultrasound)
Family history — First-degree relatives (especially brothers) of AAA patients
Incidental finding — If AAA detected on imaging for other reasons
Risk factor assessment — Smokers, hypertensive patients over 65
Preventive care — If you have multiple AAA risk factors

Screening recommendations:

Men 65-75 who ever smoked — One-time ultrasound screening
Men 65-75 never smokers — Consider screening based on risk factors
Women with risk factors — Consider screening on individual basis
First-degree relatives — Of AAA patients (especially male siblings)

Follow-up timing:

Small AAA (<4.5 cm) — Surveillance ultrasound every 6-12 months
Medium AAA (4.5-5.4 cm) — Surveillance every 3-6 months
Large AAA (≥5.5 cm) — Urgent vascular surgery consultation for repair consideration

When in doubt, seek evaluation: AAA is treacherous—rupture can occur suddenly even in previously stable aneurysms. Err on the side of caution.

19. Disease Stages, Grades and Severity

AAA is classified primarily by size and symptoms:

Size-based classification (most important):

AAA Size	Diameter	Rupture Risk	Management
Small	3.0-4.4 cm	Low (~1%/year)	Surveillance every 6-12 months
Medium	4.5-5.4 cm	Moderate (1-5%/year)	Surveillance every 3-6 months; consider repair based on other factors
Large	≥5.5 cm	High (5-20%/year)	Repair generally recommended (EVAR or open)
Giant	>7 cm	Very high	Urgent repair consideration

Symptom-based classification:

Asymptomatic (incidental) — No symptoms; most common presentation
Symptomatic (non-ruptured) — Pain or other symptoms without rupture; warning sign of impending rupture
Ruptured — Complete rupture with bleeding; surgical emergency

Anatomic classification:

Infrarenal — Below renal arteries (90-95% of cases; most amenable to EVAR)
Juxtarenal — Involves renal artery origins (more complex)
Suprarenal — Above renal arteries (requires complex repair techniques)
Thoracoabdominal — Extends from chest to abdomen (most complex, highest surgical risk)

Morphologic classification:

Fusiform — Circumferential dilation (most common)
Saccular — Localized outpouching on one side (higher rupture risk)
Inflammatory — Thickened wall, periaortic inflammation/fibrosis (2-10% of cases)

Severity determination:

Most important factors determining severity:

Size — Larger = higher rupture risk
Growth rate — Faster growth = higher risk
Symptoms — Any symptoms = higher risk
Patient factors — Age, comorbidities, surgical risk
Anatomy — Infrarenal simpler; suprarenal more complex

Clinical staging:

Stage I — Small, asymptomatic AAA (<4.5 cm): surveillance
Stage II — Medium AAA (4.5-5.4 cm): intensified surveillance, consider repair
Stage III — Large AAA (≥5.5 cm): repair indicated
Stage IV — Symptomatic or ruptured AAA: emergency

Size is the primary determinant of rupture risk and treatment timing.

20. Disease Progression

AAA typically progresses slowly over years:

Early phase (often asymptomatic):

Aortic wall degeneration begins decades before detection
Endothelial injury from hypertension, smoking, inflammation
Proteolytic activity — MMPs degrade elastin and collagen
Mild dilation — Below detection threshold on most imaging
No symptoms — Patient unaware

Progression phase:

Gradual enlargement — Average 2-4 mm/year, highly variable
Unpredictable growth — Some stable, others rapidly expand
May plateau — Some AAAs stop growing for extended periods
Accelerated growth — Some suddenly expand rapidly (reason unclear)
Thrombus formation — Laminated clot lines aneurysm sac

Growth rate factors:

Size — Larger AAAs tend to grow faster
Smoking — Current smokers have faster growth
Hypertension — Poorly controlled BP accelerates growth
COPD — Associated with faster growth
Family history — May predict faster progression

Advanced phase:

Critical enlargement — Approaching or exceeding 5.5 cm
Wall stress increases — Laplace law (stress proportional to radius)
Weakening continues — Progressive degeneration
Rupture risk rises — Exponentially with size

Rupture:

Acute event — Catastrophic tearing of aortic wall
Retroperitoneal bleeding — Initially contained, then catastrophically ruptures
Hypovolemic shock — Circulatory collapse
Multiorgan failure — If not rapidly treated

Progression is not linear:

Variable rates — Cannot predict individual growth precisely
Sudden expansion — May accelerate without clear trigger
Periods of stability — May remain stable for years then suddenly grow
Unpredictable — This is why regular surveillance essential

Why surveillance matters: Regular imaging detects rapid expansion before rupture occurs, allowing timely repair.

21. Possible Complications

Rupture (most feared and dangerous complication):

Retroperitoneal bleeding — Into space behind abdominal cavity
Hypovolemic shock — Catastrophic blood loss
Multiorgan failure — Kidney failure, cardiac collapse
High mortality — 70-90% die even with surgical treatment
Emergency surgery — Required but with poor outcomes

Aortic rupture consequences:

Massive transfusion required — Often >20 units blood products
ICU care — Prolonged critical illness
Multiple complications — Renal failure, respiratory failure, cardiac complications
High perioperative mortality — 40-50% even with surgery

Thromboembolism:

Aortic thrombus — Laminated clot lines aneurysm sac
Embolization — Clot fragments break off, travel to legs
Limb ischemia — Acute leg ischemia from embolization
Toe/f tissue loss — “blue toe syndrome” from microemboli

Compression of nearby structures:

Ureteral obstruction — Hydronephrosis, kidney damage
IVC compression — Bilateral leg swelling
Duodenal compression — Early satiety, vomiting, weight loss
Lumbar nerve compression — Radicular pain (rare)

Inflammatory AAA complications:

Periaortic fibrosis — Dense scarring around aorta
Ureteral entrapment — From inflammatory reaction
Difficult surgical dissection — Complicates repair
Higher complication rates — During repair

Aorto-enteric fistula (rare but serious):

Erosion into duodenum — Communication between aorta and intestine
GI bleeding — Massive, life-threatening hemorrhage
Sepsis — Infection complicating presentation
High mortality — Emergency surgery required

Post-repair complications:

EVAR complications: Endoleak, stent graft migration, limb occlusion, infection
Open repair complications: Wound infection, pneumonia, cardiac complications, renal failure, sexual dysfunction (retrograde ejaculation)
Graft infection — Rare but devastating; often requires graft removal
Aorto-enteric fistula — Communication between graft and bowel

Long-term complications:

Aneurysm recurrence — New AAA or other aneurysms
Graft failure — Late graft complications
Ongoing surveillance — Required lifelong after repair

Most serious complication is rupture — Prevention through timely repair is paramount.

AAAs rarely occur in isolation—most patients have widespread vascular disease:

Atherosclerotic disease elsewhere:

Coronary artery disease (CAD) — Coexists in 30-50% of AAA patients; leading cause of death after AAA repair
Peripheral artery disease (PAD) — Leg artery atherosclerosis; affects 25-40% of AAA patients
Carotid artery disease — Neck artery narrowing; stroke risk
Renal artery stenosis — Kidney artery narrowing; hypertension

Cardiovascular risk factors:

Hypertension — Present in 60-80% of AAA patients; accelerates growth and rupture
Hyperlipidemia — Elevated cholesterol; contributes to atherosclerosis
Diabetes mellitus — Present in 15-25%; influences outcomes
Smoking history — Almost universal in AAA patients; strongest modifiable risk factor
Obesity — Present in 30-50%; systemic inflammatory state

Pulmonary disease:

COPD/emphysema — Present in 30-50%; smoking-related association
Reduced pulmonary function — Increases surgical risk for open repair
Respiratory complications — Higher postoperative pulmonary complications

Other vascular aneurysms:

Thoracic aortic aneurysm — May coexist with AAA (10-20%)
Iliac artery aneurysms — Common in AAA patients
Popliteal aneurysms — Behind knee; associated with AAA
Cerebral aneurysms — Slightly increased association

Connective tissue disorders:

Inherited disorders — Ehlers-Danlos, Marfan (though more commonly cause thoracic aneurysms)
Familial AAA — Genetic predisposition in 15-25%

Renal disease:

Chronic kidney disease — From hypertension, atherosclerosis
Renal artery stenosis — Atherosclerotic narrowing contributes to hypertension

Gallbladder disease:

Gallstones — Increased association (reason unclear)

Malignancy:

Abdominal malignancy — May coexist or be discovered during AAA evaluation

Comprehensive cardiovascular assessment essential in all AAA patients—they usually have disease elsewhere.

23. Screening and Early Detection

Who should be screened:

Strong evidence for screening:

Men aged 65-75 who have ever smoked (any amount, any duration)
- Grade B recommendation: USPSTF, AAA screening guidelines
- One-time abdominal ultrasound
- Number needed to screen: ~500 to prevent one AAA death

Consider screening:

Men aged 65-75 never smoked but with other risk factors:
- Family history of AAA
- Hypertension
- Known atherosclerotic disease
- COPD
Women aged 65-75 with significant risk factors:
- Smoking history + family history
- Multiple cardiovascular risk factors
Men <65 with strong risk factors:
- Family history (especially first-degree male relative)
- Known connective tissue disorder

Screening first-degree relatives:

Brothers of AAA patients — High risk (up to 25% may have AAA)
Sons, daughters — Increased risk, consider screening starting age 50-55
Timing — Start at age 50 (or 10 years before earliest case in family)

Screening test:

Abdominal ultrasound — Gold standard for screening
- Non-invasive, no radiation
- 95% sensitivity and specificity for detecting AAA ≥3.0 cm
- Quick (<15 minutes), inexpensive, widely available
- No bowel prep required

Alternative screening:

CT abdomen — If performed for other reasons, AAA is often incidentally detected
Physical examination — Insensitive (misses many AAAs, especially in obese patients)

Frequency of screening:

One-time screening sufficient for most patients
- If AAA <3.0 cm → No further screening needed (extremely low rupture risk)
- If AAA ≥3.0 cm → Enter surveillance program

Screening benefits:

Reduces AAA mortality by ~40-50% in screened populations
Cost-effective — High value for money in targeted populations
Allows elective repair — Before rupture, dramatically better outcomes
Preventive — Detects disease before catastrophe

Screening harms:

False positives — Very rare with ultrasound
Unnecessary treatment — Some small AAAs detected may never rupture
Anxiety — About diagnosis and treatment
Cost — Minimal (one-time ultrasound)

Bottom line: If you’re a man 65-75 who ever smoked, get a one-time screening ultrasound. It could save your life.

24. How the Disease Is Diagnosed

AAA diagnosis involves imaging and clinical assessment:

Initial detection (most common scenario):

Incidental finding — On imaging for unrelated reasons (ultrasound, CT, MRI)
Screening ultrasound — In at-risk populations
Physical examination — Palpable pulsatile abdominal mass (insensitive but specific)
Symptomatic presentation — Pain, discomfort leads to imaging

Diagnostic imaging pathway:

For suspected or known AAA:

Abdominal ultrasound (first-line)
- Quick, non-invasive, inexpensive
- Excellent for size measurement, morphology
- Limited by bowel gas, obesity
- Shows thrombus, some complications
CT angiography (CTA) (definitive pre-repair imaging)
- Gold standard for AAA evaluation before treatment
- Shows precise size, extent, morphology
- Defines relationship to renal arteries, other branches
- Assesses suitability for EVAR vs. open repair
- 3D reconstruction for surgical planning
- Requires iodinated contrast
MRI angiography (alternative if contrast contraindicated)
- Excellent vascular imaging without iodinated contrast
- More expensive, less available than CT
- Longer acquisition time
- Not first-line for most patients
Plain abdominal X-ray (limited role)
- May show calcified aortic outline
- Insensitive for diagnosis
- Sometimes obtained for abdominal pain

For ruptured AAA:

Bedside ultrasound — Rapid detection in emergency setting (if patient stable)
CT angiography — If patient stable enough for transport
Immediate surgery — Don’t delay imaging for unstable patient with classic presentation

Laboratory tests (adjuncts, not diagnostic):

CBC — May show anemia (chronic or acute from rupture)
Chemistry panel — Kidney function before contrast/recovery
Blood type and crossmatch — For potential transfusion
Coagulation studies — Before surgical intervention

Diagnostic confirmation: AAA is definitively diagnosed when imaging shows aortic diameter ≥3.0 cm (1.5× normal) in the abdominal segment.

25. Physical Examination and Medical History

History focuses on risk factors: smoking, hypertension, family history of AAA (especially in brothers), known atherosclerotic disease, and any abdominal or back pain.

Examination may reveal a pulsatile, expansile mass above the umbilicus (especially in slim patients), a bruit heard over the aneurysm, and diminished peripheral pulses or signs of distal embolisation (“blue toe”). Because physical exam alone is unreliable, imaging is essential for diagnosis and sizing.

26. Diagnostic Tests and Imaging

Abdominal ultrasound — First-line and screening test; non-invasive, no radiation, accurate for measuring diameter
CT angiography (CTA) — Gold standard for pre-treatment planning; shows precise size, extent, arterial relationships, and EVAR suitability with 3D reconstruction
MR angiography (MRA) — Alternative when iodinated contrast or radiation must be avoided
Duplex ultrasound — Used for surveillance and post-EVAR follow-up

Imaging determines both the diagnosis and the treatment strategy. See our treatments overview.

27. Blood Tests, Biomarkers and Genetic Testing

There is no blood test that diagnoses AAA. Laboratory work supports risk assessment and surgical planning: lipid profile and glucose/HbA1c for cardiovascular risk, full blood count for anaemia, renal function before contrast and surgery, and coagulation, blood type and crossmatch before intervention. Inflammatory markers may be raised in inflammatory or mycotic aneurysms. Genetic testing is reserved for young patients or those with features of Marfan, Loeys-Dietz, or Ehlers-Danlos syndromes.

28. Understanding Test Results

Diameter — The single most important number; ≥3.0 cm defines an aneurysm, and 5.5 cm (men) or ~5.0 cm (women) is the usual repair threshold
Growth rate — Rapid expansion (>10 mm/year) is concerning regardless of size
Morphology — Saccular and inflammatory shapes carry higher risk
Anatomy — Neck length, angulation, and iliac vessels determine EVAR feasibility

Your specialist interprets these together with your age, fitness, and preferences.

29. Differential Diagnosis

Conditions that can mimic AAA symptoms include:

Renal colic (kidney stones) — Flank pain radiating to groin
Diverticulitis or bowel pathology — Abdominal pain and tenderness
Musculoskeletal back pain — Common and easily confused with early AAA
Pancreatitis, peptic ulcer, or biliary disease — Upper abdominal pain
Aortic dissection — Tearing pain; a distinct but related emergency

In older patients with cardiovascular risk factors and abdominal or back pain, AAA must always be excluded with imaging.

30. Specialist and Multidisciplinary Evaluation

AAA care is coordinated by a vascular surgeon within an aortic multidisciplinary team that may include endovascular specialists, cardiologists and anaesthetists (to assess fitness), radiologists (to plan the graft), and nurse specialists. Fitness assessment — cardiac stress testing, lung and kidney function — is central to choosing between surveillance, EVAR, or open repair. Find experienced teams via our hospitals and doctors directories.

31. Treatment Goals

Prevent rupture — The overriding aim
Preserve life and function — With the lowest possible procedural risk
Control risk factors — Blood pressure, smoking, cholesterol to slow growth
Maintain quality of life — Minimise unnecessary intervention for small aneurysms
Ensure durable repair — Long-lasting exclusion of the aneurysm with lifelong follow-up

32. When Is Treatment Required?

Repair is generally recommended when rupture risk outweighs procedural risk: diameter ≥5.5 cm in men (often ~5.0 cm in women, who rupture at smaller sizes), rapid growth of more than 10 mm per year, any symptomatic aneurysm regardless of size, and any ruptured or leaking AAA (emergency). Below these thresholds, surveillance with risk-factor control is safer than surgery.

33. Active Monitoring and Watchful Waiting

Most small aneurysms are managed by surveillance rather than surgery, with ultrasound roughly every 12–24 months for 3.0–3.9 cm, every 6–12 months for 4.0–4.9 cm, and every 3–6 months for 5.0–5.4 cm. During surveillance, control of blood pressure, smoking cessation, and statin therapy help limit growth. Repair is triggered when the aneurysm reaches threshold size, grows rapidly, or becomes symptomatic.

34. Medications

No drug shrinks an aneurysm, but medications reduce growth and overall cardiovascular risk: statins for cholesterol and cardiovascular protection, antihypertensives (ACE inhibitors, ARBs, beta-blockers, or calcium blockers) to control blood pressure, aspirin for coexisting atherosclerotic disease, and smoking-cessation aids. Doxycycline and beta-blockers have not been shown to reliably slow aneurysm growth.

35. Minimally Invasive Treatments

The main minimally invasive treatment for AAA is endovascular aneurysm repair (EVAR) — covered in detail in section 36. Minimally invasive approaches, including percutaneous (“keyhole”) femoral access, avoid a large abdominal incision, shorten hospital stay to 1–3 days, and speed recovery. They are especially valuable for older or higher-risk patients who could not tolerate open surgery.

36. Catheter-Based and Endovascular Treatments

Endovascular aneurysm repair (EVAR): A stent graft is delivered through small groin incisions into the femoral arteries and deployed inside the aneurysm, creating a new channel that excludes the weakened wall from pressure. It offers lower short-term mortality, less pain, and faster recovery, but requires a suitable “neck” below the renal arteries and adequate iliac access.

Fenestrated/branched EVAR (FEVAR/BEVAR) extends the technique to juxtarenal or suprarenal aneurysms using custom openings for the kidney and visceral arteries. Learn more about endovascular stenting.

37. Surgical Treatment Options

Open surgical repair is the traditional and most durable treatment. The abdomen (or flank) is opened, the aorta clamped above and below the aneurysm, and the weakened segment replaced with a synthetic (Dacron or PTFE) tube or bifurcated graft. Its advantages are excellent long-term durability and fewer late re-interventions with no need for lifelong stent surveillance; its drawbacks are a larger incision, longer hospital stay (5–10 days), recovery of 6–12 weeks, and higher short-term risk.

Open repair is favoured for younger, fitter patients, unfavourable EVAR anatomy, inflammatory or mycotic aneurysms, and previous failed endovascular repair. Ruptured AAA requires emergency repair; where anatomy allows, emergency EVAR can improve survival. The choice balances durability against short-term risk and is individualised. Explore surgery options and procedures.

38. Advanced and Emerging Treatments

Fenestrated and branched stent grafts — Extend endovascular repair to complex, near-kidney aneurysms
Off-the-shelf and physician-modified grafts — Reduce waiting time for custom devices
Endoanchors and improved sealing — Lower endoleak rates
Robotic and laparoscopic-assisted repair — Investigational at select centres

These options are best pursued at high-volume aortic centres.

39. Treatment Options Compared

Option	Invasiveness	Recovery	Durability	Best for
Surveillance	None	N/A	N/A	Small (<5.5 cm) aneurysms
EVAR	Minimally invasive	1–3 days	Good; needs lifelong follow-up	Older/higher-risk, suitable anatomy
Open repair	Major surgery	6–12 weeks	Excellent, durable	Younger/fitter, complex anatomy
FEVAR/BEVAR	Minimally invasive	Few days	Good	Juxta-/suprarenal aneurysms

Both EVAR and open repair achieve similar long-term survival; the choice depends on anatomy and fitness.

40. How Doctors Choose the Right Treatment

Decision factors include aneurysm size, growth rate and shape; anatomy (neck length, angulation, iliac access) that determines EVAR feasibility; patient age and life expectancy (younger patients often favoured for durable open repair); fitness and comorbidities; patient preference on recovery time versus lifelong surveillance; and centre expertise. A shared decision between patient and vascular team gives the best result.

41. Benefits and Risks of Treatment

Benefits: dramatically reduced rupture risk, improved life expectancy for large aneurysms, and relief of symptoms.

Risks: general surgical risks (bleeding, infection, heart, lung or kidney complications); EVAR-specific risks (endoleak, graft migration, limb occlusion, re-intervention, lifelong imaging); and open-specific risks (longer recovery, wound complications, hernia, sexual dysfunction). Elective mortality is roughly 1–3% for EVAR and 1–5% for open repair — far lower than the mortality of rupture.

42. What Happens If the Disease Is Left Untreated?

An untreated large aneurysm continues to enlarge and eventually ruptures. Rupture causes sudden catastrophic internal bleeding; most patients die before reaching hospital, and overall mortality is 70–90% even with emergency surgery. Small aneurysms managed with surveillance are not “untreated” — they are actively monitored so that timely repair can prevent this outcome. Ignoring a known large aneurysm is the most dangerous course.

43. Treatment Success and Expected Outcomes

Elective AAA repair is highly successful: over 95% of procedures successfully exclude the aneurysm, elective mortality is typically 1–5%, and rupture risk from that segment is virtually eliminated. EVAR offers lower early mortality while open repair needs fewer late re-interventions, and long-term survival is similar. Outcomes are best at high-volume centres and when aneurysms are treated electively rather than after rupture.

44. Prognosis and Long-Term Outlook

For patients whose aneurysms are detected early and repaired electively, the long-term outlook is very good, and life expectancy approaches that of the general population of similar age and cardiovascular health. Prognosis depends chiefly on timing (elective repair far outperforms emergency repair after rupture), overall cardiovascular health (most long-term deaths are from coexisting coronary and cerebrovascular disease rather than the aneurysm), adherence to surveillance after EVAR, and risk-factor control. With modern screening and repair, most patients live full lives; the outlook is poor only when an aneurysm ruptures before diagnosis, underscoring the value of screening.

45. Recovery and Rehabilitation

After EVAR — Hospital stay of 1–3 days; most patients resume light activity within 1–2 weeks and normal activity within a month
After open repair — Stay of 5–10 days (including high-dependency care); full recovery takes 6–12 weeks, with driving and heavy lifting restricted for several weeks
Rehabilitation — Graded return to walking, wound care, pain control, and lifestyle support to restore fitness and control risk factors

46. Follow-Up Tests and Long-Term Monitoring

After EVAR — Lifelong surveillance with ultrasound or CT (often at 1 month, 6–12 months, then annually) to detect endoleaks, migration, or sac growth
After open repair — Less intensive imaging, with periodic checks for graft problems or new aneurysms
Untreated small aneurysms — Continue the surveillance schedule in section 33
Cardiovascular follow-up — Ongoing control of blood pressure, cholesterol, and smoking

Missing follow-up after EVAR is a leading cause of preventable late complications.

47. Managing Recurrence or Disease Progression

New aneurysms — May form elsewhere (thoracic, iliac, popliteal); lifetime risk remains higher
Endoleaks after EVAR — May need coil embolisation, cuff extension, or conversion to open repair
Continued growth — Requires re-imaging and possible re-intervention
Risk-factor control — Sustained smoking cessation and blood-pressure management reduce recurrence

48. Living with the Disease

Many people live for years with a small, monitored aneurysm. The essentials are keeping surveillance appointments, controlling blood pressure, stopping smoking, carrying medical information so emergency teams know about the aneurysm, and staying moderately active. Anxiety about a “ticking” aneurysm is common; understanding that surveillance is protective helps.

49. Diet and Nutrition Guidelines

A heart-healthy, Mediterranean-style diet — rich in vegetables, fruit, whole grains, legumes, fish, and olive oil — supports vascular health. Limit salt for blood-pressure control, reduce saturated and trans fats to slow atherosclerosis, maintain a healthy weight, and limit alcohol and processed foods. Good nutrition will not shrink an aneurysm but helps control the risk factors that drive its growth.

50. Exercise and Physical-Activity Guidelines

Moderate aerobic exercise — walking, cycling, and swimming — is encouraged and improves cardiovascular health. Very heavy weightlifting and maximal isometric straining can spike blood pressure and are generally discouraged with a significant aneurysm. Stop with any new abdominal or back pain, and follow your surgeon’s individualised advice after repair. For most patients with small aneurysms, regular moderate activity is safe.

51. Medications, Activities and Habits to Avoid

Smoking — Avoid absolutely, as it accelerates growth and rupture
Uncontrolled hypertension — Take blood-pressure medication consistently
Heavy lifting and maximal straining — Including severe constipation-related straining
Stimulants — Some decongestants and stimulant drugs raise blood pressure
Missing surveillance — Skipping scans is a hidden but serious risk

52. Preventing the Disease or Reducing Its Risks

The key measures are not smoking (the most powerful preventable factor), controlling blood pressure and cholesterol, staying active at a healthy weight, eating a heart-healthy diet, attending screening (men 65–75 who ever smoked, and relatives of AAA patients), and managing related conditions such as diabetes and COPD. While genetics cannot be changed, these steps substantially lower risk and slow growth.

53. Pregnancy and the Disease

AAA is uncommon in women of childbearing age. When an aneurysm or an underlying connective-tissue disorder (such as Marfan or Loeys-Dietz syndrome) is present, pregnancy raises aortic risk because of increased blood volume and hormonal effects on the vessel wall. Such pregnancies require specialist pre-conception counselling and close monitoring by a combined obstetric and vascular team. Most abdominal aneurysms, however, occur well past reproductive age.

54. Disease in Children and Young Adults

AAA is rare in children and young adults and, when it occurs, usually reflects an inherited connective-tissue disorder (Marfan, Loeys-Dietz, Ehlers-Danlos), infection, or trauma rather than atherosclerosis. Young patients warrant evaluation for these causes, genetic counselling, and family screening, with management coordinated at specialist centres. See our congenital heart disease resources.

55. Disease in Older Adults

Older adults represent the majority of AAA patients. They face higher surgical risk from reduced heart, lung, and kidney reserve, so EVAR is often favoured for its lower short-term risk in the frail. Frailty, comorbidity, and life expectancy are weighed against aneurysm risk when deciding on repair, and very small aneurysms may be kept under surveillance. Careful, individualised shared decision-making is essential.

56. Emotional Health and Patient Support

Living with an aneurysm can cause anxiety, and facing surgery is stressful. Understanding that surveillance is protective reduces fear, while support groups, counselling, and involving family in decisions all help. Seek professional help for depression or anxiety, and ask your care team about mental-health and patient-support resources.

57. Preparing for Your Specialist Appointment

Bring any prior imaging and reports, a list of medications with doses, notes on any abdominal or back pain, and your history (smoking, blood pressure, family history of AAA). Bringing a companion helps you remember information, and preparing questions in advance (see the next section) makes the consultation more productive.

58. Questions to Ask Your Doctor

How large is my aneurysm, and how fast is it growing?
What is my current risk of rupture?
Do I need surveillance or repair now?
Am I a candidate for EVAR, open repair, or both?
What are the risks and benefits of each option for me?
How long will recovery take?
What follow-up and imaging will I need afterward?
What can I do to slow the aneurysm’s growth?
Which activities should I avoid?
Should my family members be screened?

59. Cost of Diagnosis and Treatment

Costs vary widely by country, hospital, and technique. The figures below are approximate and for guidance only.

Region	Diagnosis (US/CT)	EVAR	Open Repair
USA	$500–$3,000	$40,000–$80,000+	$35,000–$70,000+
UK (private)	£300–£1,500	£15,000–£30,000	£12,000–£25,000
India	$100–$500	$8,000–$18,000	$6,000–$14,000
Turkey	$150–$600	$10,000–$20,000	$8,000–$16,000
Thailand	$150–$700	$12,000–$22,000	$9,000–$18,000
Singapore	$400–$2,000	$25,000–$45,000	$20,000–$40,000

Medical-tourism destinations such as India, Turkey, and Thailand often cost 50–90% less than the US or UK. Explore destinations.

60. Factors Affecting Treatment Cost

Procedure type — EVAR stent grafts are costly; open repair has higher hospital-stay costs
Aneurysm complexity — Fenestrated/branched grafts cost significantly more
Country and hospital tier, length of stay, and ICU needs
Complications or re-interventions and lifelong follow-up imaging (especially after EVAR)
Travel, accommodation, and insurance — For patients treated abroad

61. Choosing the Right Specialist

Look for a vascular surgeon or endovascular specialist who is board-certified and experienced in aortic repair, performs a high annual volume of both EVAR and open procedures, works within a multidisciplinary aortic team, has good audited outcomes, and supports shared decision-making. Browse experienced surgeons in our doctors directory.

62. Choosing the Right Hospital or Treatment Centre

Accreditation — JCI or equivalent international standards for centres abroad
Volume — High-volume aortic centres have better outcomes
Full capability — On-site EVAR, open surgery, hybrid theatres, emergency cover, and strong ICU/imaging support
Track record — Transparent complication and mortality data

Compare facilities in our hospitals directory.

63. Getting a Second Medical Opinion

A second opinion is valuable when deciding between surveillance and repair, or between EVAR and open surgery, and when anatomy is complex. It can confirm the diagnosis, clarify timing, and reveal additional options such as fenestrated grafts at specialist centres. Bring your imaging so it can be reviewed directly. Request a second opinion through our contact page.

64. Treatment Abroad and Medical-Travel Considerations

Many patients travel for AAA repair to access high-quality care at lower cost. Choose accredited, high-volume centres with proven aortic expertise, plan for follow-up (especially lifelong EVAR surveillance back home), discuss fitness to fly with your surgeon, coordinate records with your home team, and arrange interpreters, accommodation, and recovery time. Explore leading destinations for aortic surgery.

65. Frequently Asked Questions

Is a small aneurysm dangerous? Small aneurysms (under 5.5 cm) have a low rupture risk and are safely managed with surveillance and risk-factor control.

Will my aneurysm definitely rupture? No. Many grow slowly or stabilise. Surveillance aims to repair the aneurysm before it reaches a high-risk size.

Which is better, EVAR or open repair? Neither is universally better; EVAR has lower short-term risk while open repair is more durable. The choice depends on your anatomy, age, and fitness.

Can medication cure an aneurysm? No drug shrinks an aneurysm, but statins, blood-pressure control, and stopping smoking slow growth and reduce cardiovascular risk.

Can I exercise with an aneurysm? Moderate aerobic exercise is encouraged; very heavy lifting and maximal straining should be avoided.

Do I need lifelong follow-up after repair? Yes, especially after EVAR, which requires ongoing imaging to check for endoleaks.

Should my family be screened? First-degree relatives, particularly brothers, benefit from ultrasound screening.

66. Patient Stories and Treatment Experiences

These stories are representative and anonymised for illustration.

Robert, United Kingdom — A routine NHS screening ultrasound at age 68 found a 4.2 cm aneurysm. After three years of surveillance it reached 5.6 cm and he had EVAR, going home in two days and returning to gardening within a fortnight.

Anil, India — A 72-year-old former smoker with a 6 cm aneurysm travelled to a JCI-accredited centre for EVAR at a fraction of Western costs. He recovered quickly and continues annual surveillance scans coordinated with his local doctor.

Margaret, Australia — Diagnosed at 70 with a complex juxtarenal aneurysm, she underwent fenestrated EVAR at a high-volume aortic centre and remains well, illustrating that even complex anatomy can be treated with modern techniques.

67. Latest Research and Clinical Trials

Active research includes improved stent-graft design for better sealing, fenestrated and branched devices for complex anatomy, biomarkers and advanced imaging to predict growth and rupture, the ongoing search for drugs that slow aneurysm growth, and genetic studies of inherited risk. Patients interested in trials should ask their vascular team or consult reputable registries; discuss current evidence with your specialist.

70. Medical Glossary

Aneurysm — Abnormal ballooning of a weakened artery wall
Aorta — The body’s largest artery, carrying blood from the heart
Infrarenal — Below the renal arteries; the most common AAA location
EVAR — Endovascular aneurysm repair using a stent graft via the groin
Open repair — Surgical replacement of the aneurysm with a fabric graft
Stent graft — Fabric-covered metal tube that reinforces the aorta from inside
Endoleak — Persistent blood flow into the aneurysm sac after EVAR
Rupture — A tear in the aneurysm wall causing internal bleeding
Fusiform / saccular — Uniform circumferential dilation versus a one-sided outpouching
Fenestrated graft — Stent graft with openings for kidney/visceral arteries
Surveillance — Regular imaging to monitor aneurysm size
Retroperitoneal — The space behind the abdominal cavity where the aorta lies

71. Medical Review, Editorial Policy and Last Updated Date

Last updated: 11 July 2026

This article is reviewed for accuracy against current cardiology and vascular-surgery guidance from bodies such as the ACC/AHA, the European Society for Vascular Surgery, the Society for Vascular Surgery, and the NHS. Our editorial team writes in plain language and updates content periodically as evidence evolves.

Disclaimer: This information is for education only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your individual situation.

72. Clinical Guidelines and Medical References

General guidance on abdominal aortic aneurysm is provided by the Society for Vascular Surgery (SVS), the European Society for Vascular Surgery (ESVS), ACC/AHA aortic disease guidelines, the US Preventive Services Task Force (USPSTF) screening recommendations, and NHS/NICE patient guidance and screening programmes. These sources are cited generally; consult the latest published versions and your specialist for current recommendations.

73. Book an Appointment or Request a Second Opinion

If you have an abdominal aortic aneurysm or risk factors, expert evaluation can be life-saving. Our network connects you with experienced vascular surgeons and accredited hospitals worldwide.

Book an appointment: Get started
Request a second opinion or ask a question: Contact us

Take the next step toward safe, expert aortic care today.

Abdominal Aortic Aneurysms